NCT06655727Completed
Evaluation of Dysphagia in Patients Diagnosed With Parkinson's Disease by Ultrasound
Evaluation of Dysphagia in Patients Diagnosed With Parkinson's Disease by Ultrasound: A Controlled Study
Source: ClinicalTrials.gov · Last updated 29 Jan 2025
Brief summary (registry, in English)
The primary aim of this study is to perform an ultrasonographic swallowing assessment in Parkinson's patients and healthy volunteers and compare the findings with those from clinical swallowing evaluations. The secondary aim is to examine the relationship between dysphagia and functional status.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 22 Oct 2024
- Start date
- 25 Oct 2024
- Primary completion date
- 15 Nov 2024
- Lead sponsor
- Beylikduzu State Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT06655727
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 25 Oct 2024 to the primary completion date, 15 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having received voice or swallowing therapy in the last 6 months.
Other illness
- Presence of head or neck cancer that could cause dysphagia.
- History of radiotherapy or surgery in the head and neck region.
- Diagnosis of vascular parkinsonism or stroke.
- Presence of cardiopulmonary disease that could affect swallowing or breathing.
- Presence of a diagnosed psychiatric disorder.
Who the study is looking for
- Diagnosis of idiopathic Parkinson's disease by a neurologist.
- Being in stages 1-3 according to the Modified Hoehn-Yahr Staging Scale.
- Scoring at least 24 on the Mini-Mental State Examination (MMSE).
- Not having received any therapy or treatment affecting swallowing, other than routine medication for Parkinson's disease.
Age in the registry: 40 years to 80 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beylikdüzü State Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.